FDA approves new pancreatic cancer pill priced at $480,000 per year
A groundbreaking new pill that can significantly extend the lives of some pancreatic cancer patients has officially been approved by the FDA. There is just one jaw-dropping catch—it comes with a heavy price tag. The newly approved drug, called Rasonque, costs $663 per pill—roughly $39,800 for